C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/14 (2006.01) A61K 31/519 (2006.01) A61P 25/14 (2006.01) A61P 25/16 (2006.01)
Patent
CA 2623047
The compound having the structural formula I, or a pharmaceutically acceptable salt thereof, is disclosed, as well as its use in the treatment of central nervous system diseases, in particular Parkinson's disease, Extra Pyramidal Syndrome, restless legs syndrome and attention deficit hyperactivity disorder, pharmaceutical compositions comprising it, and combinations with other agents.
La présente invention concerne le composé de formule structurelle I, ou un sel de qualité pharmaceutique dudit composé, ainsi que son emploi dans le traitement de maladies du système nerveux central, en particulier la maladie de Parkinson, le Syndrome Extrapyramidal, le syndrome des jambes sans repos ou le trouble de déficit d'attention avec hyperactivité, de même que les préparations pharmaceutiques comprenant ledit composé et ses combinaisons avec d'autres agents.
Boyle Craig D.
Chackalamannil Samuel
Lachowicz Jean E.
Shah Unmesh G.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazi... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazi..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazi... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1920153